title: Suboptimum use of FDA drug advisory committees.
authors.forename: Asa L
authors.initials: AL
authors.lastname: Tapley
authors.forename: Peter
authors.initials: P
authors.lastname: Lurie
authors.forename: Sidney M
authors.initials: SM
authors.lastname: Wolfe
mesh_terms: D026683:Advisory Committees / Q000706:statistics & numerical data* / Q000639:trends; D017277:Drug Approval; D014481:United States; D014486:United States Food and Drug Administration